These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

795 related items for PubMed ID: 18337089

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor binding protein-4 and -5 modulate ligand-dependent estrogen receptor-α activation in breast cancer cells in an IGF-independent manner.
    Hermani A, Shukla A, Medunjanin S, Werner H, Mayer D.
    Cell Signal; 2013 Jun; 25(6):1395-402. PubMed ID: 23499909
    [Abstract] [Full Text] [Related]

  • 3. Estrogen signaling via a linear pathway involving insulin-like growth factor I receptor, matrix metalloproteinases, and epidermal growth factor receptor to activate mitogen-activated protein kinase in MCF-7 breast cancer cells.
    Song RX, Zhang Z, Chen Y, Bao Y, Santen RJ.
    Endocrinology; 2007 Aug; 148(8):4091-101. PubMed ID: 17525128
    [Abstract] [Full Text] [Related]

  • 4. Affinity for the insulin-like growth factor-II (IGF-II) receptor inhibits autocrine IGF-II activity in MCF-7 breast cancer cells.
    Ellis MJ, Leav BA, Yang Z, Rasmussen A, Pearce A, Zweibel JA, Lippman ME, Cullen KJ.
    Mol Endocrinol; 1996 Mar; 10(3):286-97. PubMed ID: 8833657
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Expression of insulin-like growth factors and their binding proteins in the estrogen responsive Ishikawa human endometrial cancer cell line.
    Hana V, Murphy LJ.
    Endocrinology; 1994 Dec; 135(6):2511-6. PubMed ID: 7527333
    [Abstract] [Full Text] [Related]

  • 7. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M, Morelli C, Mauro L, Andò S, Surmacz E.
    Cancer Res; 2001 Sep 15; 61(18):6747-54. PubMed ID: 11559546
    [Abstract] [Full Text] [Related]

  • 8. Insulin-like growth factor-II (IGF-II): a potential autocrine/paracrine growth factor for human breast cancer acting via the IGF-I receptor.
    Osborne CK, Coronado EB, Kitten LJ, Arteaga CI, Fuqua SA, Ramasharma K, Marshall M, Li CH.
    Mol Endocrinol; 1989 Nov 15; 3(11):1701-9. PubMed ID: 2558302
    [Abstract] [Full Text] [Related]

  • 9. Specific targeting of insulin-like growth factor 1 receptor signaling in human estrogen dependent breast cancer cell by a novel tyrosine-based benzoxazepine derivative.
    Chakravarti B, Siddiqui JA, Dwivedi SK, Deshpande S, Samanta K, Bhatta RS, Panda G, Prabhakar YS, Konwar R, Sanyal S, Chattopadhyay N.
    Mol Cell Endocrinol; 2011 May 16; 338(1-2):68-78. PubMed ID: 21457754
    [Abstract] [Full Text] [Related]

  • 10. Overexpressed IGF-I receptors reduce estrogen growth requirements, enhance survival, and promote E-cadherin-mediated cell-cell adhesion in human breast cancer cells.
    Guvakova MA, Surmacz E.
    Exp Cell Res; 1997 Feb 25; 231(1):149-62. PubMed ID: 9056422
    [Abstract] [Full Text] [Related]

  • 11. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors.
    Read LD, Greene GL, Katzenellenbogen BS.
    Mol Endocrinol; 1989 Feb 25; 3(2):295-304. PubMed ID: 2785242
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S, Zhang P, Guler RL, Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV.
    Cancer Res; 2001 Aug 01; 61(15):5771-7. PubMed ID: 11479214
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role of estrogen receptor (ER) alpha in insulin-like growth factor (IGF)-I-induced responses in MCF-7 breast cancer cells.
    Zhang S, Li X, Burghardt R, Smith R, Safe SH.
    J Mol Endocrinol; 2005 Dec 01; 35(3):433-47. PubMed ID: 16326831
    [Abstract] [Full Text] [Related]

  • 16. The relationship between the insulin-like growth factor-1 system and the oestrogen metabolising enzymes in breast cancer tissue and its adjacent non-cancerous tissue.
    Chong YM, Colston K, Jiang WG, Sharma AK, Mokbel K.
    Breast Cancer Res Treat; 2006 Oct 01; 99(3):275-88. PubMed ID: 16752221
    [Abstract] [Full Text] [Related]

  • 17. Hexachlorobenzene induces cell proliferation and IGF-I signaling pathway in an estrogen receptor alpha-dependent manner in MCF-7 breast cancer cell line.
    García MA, Peña D, Alvarez L, Cocca C, Pontillo C, Bergoc R, de Pisarev DK, Randi A.
    Toxicol Lett; 2010 Feb 01; 192(2):195-205. PubMed ID: 19879930
    [Abstract] [Full Text] [Related]

  • 18. Autocrine IGF-I/insulin receptor axis compensates for inhibition of AKT in ER-positive breast cancer cells with resistance to estrogen deprivation.
    Fox EM, Kuba MG, Miller TW, Davies BR, Arteaga CL.
    Breast Cancer Res; 2013 Feb 01; 15(4):R55. PubMed ID: 23844554
    [Abstract] [Full Text] [Related]

  • 19. Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells.
    Chen WF, Wong MS.
    J Clin Endocrinol Metab; 2004 May 01; 89(5):2351-9. PubMed ID: 15126563
    [Abstract] [Full Text] [Related]

  • 20. Nordihydroguaiaretic acid (NDGA), an inhibitor of the HER2 and IGF-1 receptor tyrosine kinases, blocks the growth of HER2-overexpressing human breast cancer cells.
    Zavodovskaya M, Campbell MJ, Maddux BA, Shiry L, Allan G, Hodges L, Kushner P, Kerner JA, Youngren JF, Goldfine ID.
    J Cell Biochem; 2008 Feb 01; 103(2):624-35. PubMed ID: 17562544
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.